The Lancet on Thursday retracted a study that raised safety fears over the use of a drug favored by President Donald Trump to treat COVID-19, after the paper’s authors said they could no longer vouch for its underlying data.
Subscribe to France 24 now:
FRANCE 24 live news stream: all the latest news 24/7
Visit our website:
Subscribe to our YouTube channel:
Like us on Facebook: